EXR Financial Statements & Analysis
Complete financial statements for EXR including income statement, balance sheet, and cash flow statement. Analyze EXR's revenue growth, profit margins, earnings trends, debt levels, and cash flow generation.
Financial Health Score
Financial Health Score
62
Good
Poor (0-40)Neutral (40-60)Good (60-100)
Income Statement
Revenue
27.2% ↑
Net Income
6.4% ↑
Gross Margin
-2.2% ↓
Operating Margin
-11.1% ↓
Balance Sheet
Current Ratio
9.0% ↑
Debt to Equity
19.4% ↓
Asset Turnover
21.1% ↑
Cash Flow
Operating Cash Flow
34.6% ↑
Net Cash Flow
420.1% ↑
Free Cash Flow
34.7% ↑
Cash Flow to Debt
16.2% ↑
Income Statement Comparison
Revenue & Net Income
Period Comparison
| Metric | 2023 | 2024 | Change | Impact |
|---|---|---|---|---|
| Revenue | 2.56B | 3.26B | 27.2% | |
| Gross Profit | 1.89B | 2.35B | 24.5% | |
| Operating Income | 1.17B | 1.32B | 13.1% | |
| Net Income | 803.20M | 854.68M | 6.4% | |
| EPS | 4.74 | 4.03 | 15.0% | |
| EBITDA | 1.74B | 2.31B | 32.6% | |
| Gross Margin | 73.80% | 72.20% | 2.2% | |
| Operating Margin | 45.70% | 40.63% | 11.1% | |
| Net Income Margin | 31.37% | 26.24% | 16.4% | |
| R&D Expenses | 0 | 0 | 0.0% |
Income Statement Full Table
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Revenue | 3.26B | 2.56B | 1.92B | 1.58B | 1.36B |
| Gross Profit | 2.35B | 1.89B | 1.46B | 1.18B | 969.10M |
| Operating Income | 1.32B | 1.17B | 1.05B | 975.95M | 666.14M |
| Net Income | 854.68M | 803.20M | 860.69M | 827.65M | 481.78M |
| EPS | 4.03 | 4.74 | 6.41 | 6.2 | 3.71 |
| EBITDA | 2.31B | 1.74B | 1.33B | 1.05B | 846.01M |
| Gross Margin | 72.20% | 73.80% | 75.63% | 74.76% | 71.46% |
| Operating Margin | 40.63% | 45.70% | 54.59% | 61.87% | 49.12% |
| Net Income Margin | 26.24% | 31.37% | 44.73% | 52.47% | 35.52% |
| R&D Expenses | 0 | 0 | 0 | 0 | 0 |